FS.04: Featured Science in Acute Coronary Syndromes (AHA 2026) - Oct 8, 2026 - Pres time: Nov 7, 2026; 01:30 PM - 02:45 PM; Location: Heart Theater 2‚ Science and Technology Hall‚ South Hall‚ Heart Hub; In-Person; "VIHP – Two-Week Helicobacter Pylori Eradication versus Six-Month Pantoprazole for Prevention of Gastrointestinal Bleeding After Percutaneous Coronary Intervention for Acute Coronary Syndrome: The VIHP Randomized Trial * SWITCH SWEDEHEART – Contemporary Cost-Effectiveness of Default Prasugrel versus Ticagrelor Policies in Acute Coronary Syndromes * DAPT-SHOCK-AMI – Multimodality Cardiac Imaging Substudy of the DAPT-SHOCK-AMI Randomized Trial: Echocardiographic and Cardiac Magnetic Resonance Assessment of Cangrelor vs. Crushed Ticagrelor in Cardiogenic Shock Complicating Acute Myocardial Infarction PRESC1SE-MI – One-Year Outcomes After Implementation of the 0/1-Hour Pathway: A Prespecified Secondary Analysis of a Randomized Controlled Trial * CHIP-BCIS3 – Periprocedural Myocardial Injury, Microaxial Flow Pump Use and Cardiovascular Death After Complex Percutaneous Coronary Intervention: Insights From a Pre-Specified Analysis of the CHIP-BCIS3 Trial"
Late-breaking abstract • Acute Coronary Syndrome • Cardiovascular • Gastroenterology • Infectious Disease • Myocardial Infarction
|